Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The 10th World Congress on Health Economics: Health Economics in the Age of Longevity, took place in Dublin, Ireland, 13-16 July 2014

HERC Sessions and Presentations

Organised Session - Rachael Morton and Borislava Mihaylova

Economic Analyses in Chronic Kidney Disease: The Study of Heart and Renal Protection

Seamus Kent: Estimation of hospital care costs and health-related quality of life in chronic kidney disease patients.
Iryna Schlackow: A lifetime model in Chronic Kidney Disease: the SHARP Chronic Kidney – Cardiovascular Disease model.
Rachael Morton: The impact of social disadvantage on cardiovascular outcomes and mortality in people with moderate-to-advanced chronic kidney disease: The Study of Heart and Renal Protection.

Organised Session - Rachael Morton

Economic Anayses of Cancer Screening and Genomics

Jose Leal: Cost-effectiveness of prostate cancer screening across jurisdictions in the absence of direct evidence: the case studies of England and the Republic of Ireland.

Oral Presentations

Alastair Gray: Adverse medical events in the UK National Health Service: comparison of frequency and severity over time based on repeat population surveys.
Filipa Landeiro: The impact of social isolation on delayed hospital discharges of older hip fracture patients and associated costs.
Ramon Luengo-Fernandez: Economic burden of cancer: evidence from the European Union.
Maria Alva: Self-reported quality of life as an independent predictor of mortality in type-2 diabetes: relevance of unobserved heterogeneity.
Richéal Burns: A Cost-Effectiveness Analysis of PSA testing for the secondary prevention of Prostate Cancer in the Republic of Ireland.
Judit Simon: Measuring the capability sets of people with severe mental health disorders using a novel multi-dimensional instrument: the OxCAP-MH.